Metraipolis › archive › dc_1499db5905e7
Within-trial cost-effectiveness of lifestyle intervention using a 3-tier shared care approach for pregnancy outcomes in Chinese women with gestational diabetes — Europe PMC PMID:32817701
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/32817701
- DOI
- 10.1371/journal.pone.0237738
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-07T17:31:21.109Z
- SHA-256 of the archived text
d5be62432a074488bee27ba50862ff69575b622e24f20424ca8bb3eaf8220ec9- Stable URL of this page
https://metraipolis.com/documento/dc_1499db5905e7
How to cite
Within-trial cost-effectiveness of lifestyle intervention using a 3-tier shared care approach for pregnancy outcomes in Chinese women with gestational diabetes — Europe PMC PMID:32817701 — Europe PMC (en), https://europepmc.org/article/MED/32817701 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_1499db5905e7 (Metraipolis archive dc_1499db5905e7, sha256 d5be62432a074488bee27ba50862ff69575b622e24f20424ca8bb3eaf8220ec9)
BibTeX
@misc{dc1499db5905e7,
title = {Within-trial cost-effectiveness of lifestyle intervention using a 3-tier shared care approach for pregnancy outcomes in Chinese women with gestational diabetes — Europe PMC PMID:32817701},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/32817701},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_1499db5905e7; sha256 d5be62432a074488bee27ba50862ff69575b622e24f20424ca8bb3eaf8220ec9},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32817701. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
This study assessed within-trial cost-effectiveness of a shared care program (SC, n = 339) for pregnancy outcomes compared to usual care (UC, n = 361), as implemented in a randomized trial of Chinese women with gestational diabetes (GDM). SC consisted of an individualized dietary advice and physical activity counseling program. The UC was a one-time group education program. The effectiveness was measured by number needed to treat (NNT) to prevent one macrosomia/large for gestational age (LGA) infant. The cost-effectiveness was measured by incremental cost-effectiveness ratio in terms of cost (2012 Chinese Yuan/US dollar) per case of macrosomia and LGA prevented. The study took both a health care system and a societal perspective. This study found that the NNT was 16/14 for macrosomia/LGA. The incremental cost for treating a pregnant woman was ¥1,877 ($298) from a health care system perspective and ¥2,056 ($327) from a societal perspective. The cost of preventing a case of macrosomia/LGA from the two corresponding perspectives were ¥30,032/¥26,278 ($4,775/$4,178) and ¥32,896/¥28,784 ($5,230/$4,577), respectively. Considering the potential severe adverse health and economic consequences of a macrosomia/LGA infant, our findings suggest that implementing this lifestyle intervention for women with GDM is an efficient use of health care resources. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2020 (prima pubblicazione 2020-08-20). Identificativi: PMID 32817701 · PMCID PMC7444483 · DOI 10.1371/journal.pone.0237738. Descrittori MeSH principali: Cost-Benefit Analysis. Pagina: https://europepmc.org/article/MED/32817701 — https://doi.org/10.1371/journal.pone.0237738. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-07T17:27:20.482Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.